from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2307c/-

LFCtreatmentdescriptionclass of inhibitor

0.191

Amikacinug/mL Amikacintranslation

0.276

Cap5-10ug/mL Capreomycintranslation

1.122

Rox10-50 ug/mL Roxithromycintranslation

-0.016

SM2-5 ug/mL Streptomycintranslation

1.342

Tet5-10 ug/mL Tetracyclinetranslation

-0.446

Rif0.2-5ug/mL Rifampicintranscription

0.161

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.109

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.783

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.417

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.821

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.501

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.129

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.659

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.087

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.163

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.291

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.106

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.309

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.724

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.689

KCN5-20 ug/mL Potassium cyaniderespiration

0.820

NaN30.2-2 mM Sodium aziderespiration

0.180

Nigericin50 uM Nigericinrespiration

-0.417

TRC10-150 ug/mL Triclosanrespiration

-1.043

TRZ10-25 ug/mL Thioridazinerespiration

1.973

Valinomycin0.5-10 uM Valinomycinrespiration

1.014

ZnSO42 mM ZnSO4respiration

-0.351

menadione6-10 ug/mL Menadionerespiration

-0.080

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.467

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.362

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.467

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.824

NRP_1Non-replicating persistence stage 1dosRassociated

-0.219

Amp0.2mg/mL AmpicillincellWall

0.016

Cephalexin20-100 ug/mL CephalexincellWall

-0.336

Cerulenin0.32-5 ug/mL CerulenincellWall

0.326

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.005

EMB10-20 ug/mL EthambutolcellWall

0.119

Eta12-40 ug/mL EthionamidecellWall

0.554

INH0.2-0.4 ug/mL IsoniazidcellWall

0.010

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.448

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.447

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.108

BZA0.12 mg/mL BenzamidearomaticAmides

-0.073

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.101

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.419

H2O24 mM hydrogen peroxideDNAdamaging

-0.265

Levo10 ug/mL LevofloxacinDNAdamaging

-0.466

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.497

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.268

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.019

UVUV-irradiationDNAdamaging

1.514

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.076

Antimycin12.5-50 ug/mL Antimycin A?

-0.518

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.046

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.214

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.314

PA8240.2-2 ug/mL PA-824?

0.538

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.269

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.601

Verapamil50 uM Verapamil?

-0.053

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.683

methoxatin10-20 ug/mL Methoxatin?